Bipolar Spectrum disorders in Parkinson's disease: a systematic evaluation.


Journal

CNS spectrums
ISSN: 1092-8529
Titre abrégé: CNS Spectr
Pays: United States
ID NLM: 9702877

Informations de publication

Date de publication:
06 2022
Historique:
pubmed: 8 12 2020
medline: 26 5 2022
entrez: 7 12 2020
Statut: ppublish

Résumé

Psychiatric disorders are very common in patients affected by Parkinson's disease (PD). However, comorbidity with Bipolar Spectrum disorders is understudied. The aim of this study is to explore the clinical correlates of PD associated with Bipolar Spectrum disorders. One hundred PD patients were screened for psychiatric comorbidities, cognitive profile, motor, and non-motor symptoms. The sample was divided into three groups: PD-patients with Bipolar Spectrum disorders (bipolar disorder type I, type II, and spontaneous or induced hypomania; N = 32), PD-patients with others psychiatric comorbidities (N = 39), PD-patients without psychiatric comorbidities (N = 29). Clinical features were compared among the groups using analysis of variance and chi-square test. A logistic regression was performed to evaluate the association between Bipolar Spectrum disorders and early onset of PD (≤50 years) controlling for lifetime antipsychotic use. In comparison with PD patients with and without other psychiatric comorbidity, subjects affected by Bipolar Spectrum disorders were younger, showed more frequently an early onset PD, reported more involuntary movements and a higher rate of impulse control disorders and compulsive behaviors. No differences were observed in indexes of exposure to dopamine agonist treatments. The early onset of PD was predicted by Bipolar Spectrum comorbidity, independently from lifetime antipsychotic use. Bipolar Spectrum disorders are common in early onset PD. The presence of bipolar comorbidity could identify a particular subtype of PD, showing higher rates of neurological and psychiatric complications and deserving further investigation.

Identifiants

pubmed: 33280618
doi: 10.1017/S1092852920002126
pii: S1092852920002126
doi:

Substances chimiques

Antipsychotic Agents 0
Dopamine Agonists 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

355-361

Auteurs

Silvia Bacciardi (S)

North-Western Tuscany Local Health Unit, Department of Psychiatry, Tuscany NHS, Viareggio, Italy.
Pisa-School of Clinical and Experimental Psychiatry, Institute for Improving Neuroscientific Knowledge, Pisa, Italy.

Camilla Elefante (C)

Department of Clinical and Experimental Medicine-Psychiatry Unit, University of Pisa, Pisa, Italy.

Giulio Emilio Brancati (GE)

Department of Clinical and Experimental Medicine-Psychiatry Unit, University of Pisa, Pisa, Italy.

Sonia Mazzucchi (S)

Department of Clinical and Experimental Medicine-Neurology Unit, University of Pisa, Pisa, Italy.

Eleonora Del Prete (E)

Department of Clinical and Experimental Medicine-Neurology Unit, University of Pisa, Pisa, Italy.

Daniela Frosini (D)

Department of Clinical and Experimental Medicine-Neurology Unit, University of Pisa, Pisa, Italy.

Icro Maremmani (I)

Department of Clinical and Experimental Medicine-Psychiatry Unit, University of Pisa, Pisa, Italy.
Association for the Application of Neuroscientific Knowledge to Social Aims (AU-CNS), Lucca, Italy.
G. De Lisio Institute of Behavioral Sciences, Pisa, Italy.

Lorenzo Lattanzi (L)

Department of Clinical and Experimental Medicine-Psychiatry Unit, University of Pisa, Pisa, Italy.

Roberto Ceravolo (R)

Department of Clinical and Experimental Medicine-Neurology Unit, University of Pisa, Pisa, Italy.

Ubaldo Bonuccelli (U)

Department of Clinical and Experimental Medicine-Neurology Unit, University of Pisa, Pisa, Italy.

Giulio Perugi (G)

Department of Clinical and Experimental Medicine-Psychiatry Unit, University of Pisa, Pisa, Italy.
G. De Lisio Institute of Behavioral Sciences, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH